AptarGroup Q1 revenue up 9% to $845M; adjusted EPS down to $0.96 from $1.05

APTARGROUP, INC.

2022-Q1 EPS reported $0.93 revenue$844,932,000

Reported sales $845M (+9% YoY); core sales +13% with double-digit growth in all segments.
Adjusted EPS $0.96 vs $1.05 prior year; reported EPS $0.93 included $0.19 unrealized gain in prior year.
Pharma core sales +13%; demand for allergic rhinitis and asthma devices recovering.
Q2 2022 adjusted EPS guidance $0.92-$1.02; midpoint +14% on constant-currency basis.
Dividend maintained at $0.38/share; $16M share repurchases in Q1, $184M remaining authorization.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.